24/7 MN – (NASDAQ: ACRX) stock is moving up this morning on news from Seeking Alpha about the company’s plan B.

The stock is up 23% in early trading on more than 5400 trades and 3.4 million in volume. Shares are trading around .31

[mstock id=”73007″ asset=”acrx”]

AcelRx Pharmaceuticals: Finally, Plan B


  • On May 16, 2022 ACRX announced the company was in active discussions with potential commercial partners to take on DSUVIA.
  • In such case, ACRX would essentially give up the main asset on which its story was built on so far.
  • The company has acquired further assets over the past twelve months, ensuring a basis for further revenue.
  • Without knowledge of the DSUVIA deal it is hard to assess the prospect, so I retain a Neutral rating with a tilt to Buy, as I believe in some short-term upside potential.

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.